Excitotoxicity and bioenergetics in glutaryl-CoA dehydrogenase deficiency

Stefan Kölker, D. M. Koeller, S. Sauer, F. Hörster, M. A. Schwab, G. F. Hoffmann, K. Ullrich, J. G. Okun

Research output: Contribution to journalArticlepeer-review

40 Scopus citations


Glutaryl-CoA dehydrogenase deficiency is an inherited organic acid disorder with predominantly neurological presentation. The biochemical hallmark of this disease is an accumulation and enhanced urinary excretion of two key organic acids, glutaric acid and 3-hydroxyglutaric acid. If untreated, acute striatal damage is often precipitated by febrile illnesses during a vulnerable period of brain development in infancy or early childhood, resulting in a dystonic dyskinetic movement disorder. 3-Hydroxyglutaric and glutaric acids are structurally similar to glutamate, the main excitatory amino acid of the human brain, and are considered to play an important role in the pathophysiology of this disease. 3-Hydroxyglutaric acid induces excitotoxic cell damage specifically via activation of N-methyl-D-aspartate receptors. It has also been suggested that secondary amplification loops potentiate the neurotoxic properties of these organic acids. Probable mechanisms for this effect include cytokine-stimulated NO production, a decrease in energy metabolism, and reduction of cellular creatine phosphate levels. Finally, maturation-dependent changes in the expression of neuronal glutamate receptors may affect the vulnerability of the immature brain to excitotoxic cell damage in this disease.

Original languageEnglish (US)
Pages (from-to)805-812
Number of pages8
JournalJournal of inherited metabolic disease
Issue number6
StatePublished - 2004

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'Excitotoxicity and bioenergetics in glutaryl-CoA dehydrogenase deficiency'. Together they form a unique fingerprint.

Cite this